Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AIMS: AXERT Time vs Intensity Migraine Study
NCT00212823Phase 4Completed
- Sponsor
- Johnson & Johnson
- Start
- Jun 2004
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of almotriptan in migraine, sponsored by Johnson & Johnson. Started Jun 2004; status: completed.
02
Drugs
almotriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00212823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212823.